US 10597661
Polynucleotide agents targeting patatin-like phospholipase domain containing 3 (PNPLA3) and methods of use thereof
granted A61KA61K31/7008A61K31/712
Quick answer
US patent 10597661 (Polynucleotide agents targeting patatin-like phospholipase domain containing 3 (PNPLA3) and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/7008, A61K31/712, A61K31/7125, A61K47/546